These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 940644)

  • 1. Quadrichemotherapy for advanced ovarian carcinoma.
    Kessinger A; Foley JF; Lemon HM
    Obstet Gynecol; 1976 Aug; 48(2):134-6. PubMed ID: 940644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil, vincristine, and prednisone compared with single-agent L-phenylalanine mustard for patients with operable breast carcinoma and positive axillary lymph nodes: 20-year results of a Southwest Oncology Group study.
    Rivkin SE; Green SJ; Lew D; Costanzi JJ; Athens JW; Osborne CK; Vaughn CB; Martino S
    Cancer; 2003 Jan; 97(1):21-9. PubMed ID: 12491501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [1st report on programmed chemotherapy of ovarian carcinoma].
    Frank S; Richter K; Ehrhart H; Penning W; Meister P; Schmidt D; Götz A
    Fortschr Med; 1975 Oct; 93(28):1309-12. PubMed ID: 1228086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. VP-16 in combinations for first-line treatment of malignant germ-cell tumors and gestational choriocarcinoma.
    Newlands ES
    Semin Oncol; 1985 Mar; 12(1 Suppl 2):37-41. PubMed ID: 2579442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotherapy in advanced ovarian carcinoma: current standards of care based on randomized trials.
    Thigpen T; Vance R; Puneky L; Khansur T
    Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S97-107. PubMed ID: 7835816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemotherapy in bronchogenic carcinoma.
    Ojala A; Nikkanen VN; Palojoki A; Paloheimo S
    Ann Clin Res; 1977 Feb; 9(1):12-4. PubMed ID: 329741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination chemotherapy in the management of ovarian germ cell malignancies.
    Schwartz PE
    Obstet Gynecol; 1984 Oct; 64(4):564-72. PubMed ID: 6207473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized trial of initial therapy with melphalan versus cisplatin-based combination chemotherapy in patients with advanced ovarian carcinoma: initial and long term results--Eastern Cooperative Oncology Group Study E2878.
    Wadler S; Yeap B; Vogl S; Carbone P
    Cancer; 1996 Feb; 77(4):733-42. PubMed ID: 8616766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase II trial of a combination of cyclosphamide, vincristine, and methotrexate in advanced colorectal carcinoma.
    Taylor SG; Desai SA; DeWys WD
    Cancer Treat Rep; 1978 Aug; 62(8):1203-5. PubMed ID: 356978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methotrexate (NSC-740) with citrovorum factor (NSC-3590) rescue, alone and in combination with cyclophosphamide (NSC-26271), in ovarian cancer.
    Barlow JJ; Piver MS
    Cancer Treat Rep; 1976 May; 60(5):527-33. PubMed ID: 1086714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Combination chemotherapy of anaplastic carcinoma with adriamycin, vincristine, methotrexate and cyclophosphamide (author's transl)].
    Chauvergne J; Durand M; Hoerni B; Brunet R; Bui BN
    Bull Cancer; 1980; 67(2):167-74. PubMed ID: 7448439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single agent vs combination chemotherapy in the treatment of ovarian cancer.
    Barlow JJ; Piver MS
    Obstet Gynecol; 1977 May; 49(5):609-11. PubMed ID: 850579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Combined chemo- and hormone-therapy in advanced ovarian carcinoma--theoretical, experimental foundations and clinical results].
    Sevelda P
    Wien Klin Wochenschr Suppl; 1990; 183():3-29. PubMed ID: 2145702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cisplatin-MECY (methotrexate-leucovorin rescue plus cyclophosphamide) versus cisplatin-CHAD (cyclophosphamide, hexamethylmelamine, doxorubicin, and cisplatin) as initial chemotherapy in stage III-IV ovarian adenocarcinoma.
    Barlow JJ; Lele SB
    Cancer Treat Rep; 1984 Dec; 68(12):1433-8. PubMed ID: 6439408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotherapy of ovarian cancer.
    Dimitriades M; Papadimitriou GC; Razis DV; Panopoulos C; Midoulas N
    Int Surg; 1978 Feb; 63(2):81-3. PubMed ID: 632023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary treatment of advanced ovarian adenocarcinoma, stages III and IV.
    Piver S; Barlow JJ; Chung WS; Lee FT; Vongtama V
    Natl Cancer Inst Monogr; 1975 Oct; 42():177-82. PubMed ID: 825780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclophosphamide plus cis-platinum in combination: treatment program for stage III or IV ovarian carcinoma.
    Decker DG; Fleming TR; Malkasian GD; Webb MJ; Jeffries JA; Edmonson JH
    Obstet Gynecol; 1982 Oct; 60(4):481-7. PubMed ID: 6889714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase I trial of carboplatin, paclitaxel, etoposide, and cyclophosphamide with granulocyte colony stimulating factor as first-line therapy for patients with advanced epithelial ovarian cancer.
    Tung N; Berkowitz R; Matulonis U; Quartulli M; Seiden M; Kim Y; Niloff J; Cannistra SA
    Gynecol Oncol; 2000 May; 77(2):271-7. PubMed ID: 10785477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemotherapy in ovarian carcinoma recurrent after radiation therapy.
    Lele SB; Piver MS; Barlow JJ
    Obstet Gynecol; 1978 Jan; 51(1):101-4. PubMed ID: 619324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ovarian carcinoma: the role of chemotherapy.
    Thigpen JT; Vance RB; Lambuth BW
    Semin Oncol; 1988 Jun; 15(3 Suppl 3):16-23. PubMed ID: 3293214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.